A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)

NCT06273774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: Elpipodect
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC